Otros idiomas Trevena, Inc.

Acciones

TRVN

US89532E2081

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
0,391 ^USD	-4,40 %		+11,08 %	-45,85 %

01/04	Trevena, Inc. informa de los resultados del ejercicio finalizado el 31 de diciembre de 2023	CI
01/04	Trevena, Inc. informa de los resultados del cuarto trimestre finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Trevena, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Trevena: Q4 Earnings Snapshot	01/04
Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update	01/04
Trevena : Reports Fourth Quarter 2023 Results and Provides Corporate Update - Form 8-K	01/04
Trevena, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01/04
Trevena, Inc. Promotion of Barry Shin to the Position of Executive Vice President and Chief Operating Officer	01/02
Trevena Raises $4 Million via Placement, Warrant Exercise	28/12
Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise	28/12
Trevena, Inc. announced that it has received $1.945934 million in funding	28/12
Trevena to Raise $4 Million From Private Placement, Warrants Exercise Agreements	27/12
Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise	27/12
Trevena, Inc. announced that it expects to receive $1.945934 million in funding	27/12
Trevena Announces TRV045 Presentation at the American College of Neuropsychopharmacology 62nd Annual Meeting	04/12
Trevena Awarded OLINVYK Agreement with Premier, Inc.	04/12
Trevena Inc. Receives OLINVYK Agreement with Premier, Inc	04/12
Trevena Files $200 Million Mixed Shelf	04/12
Trevena Announces Acceptance of Abstract Examining the Use of OLINVYK in Patients with Acute Burn Injuries	30/11
Trevena, Inc. Announces Acceptance of Abstract Examining the Use of Olinvyk in Patients with Acute Burn Injuries	30/11
Trevena: Q3 Earnings Snapshot	14/11
Trevena, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Trevena, Inc.

Acciones

TRVN

US89532E2081

Otros idiomas

Filtros